A rich pipeline of innovative medicines
Covering a wide range of disease areas including glucose-lowering, anti-cancer and rare diseases
MORE +
CGeneTech
Shengshi Taike Biopharmaceutical Technology (Suzhou) Co., Ltd. is a biotechnology company in the commercial stage, and its core product, Class 1 innovative drug sengliptin (Trade name: Shengjie Wei®), has been approved for listing. The company was founded in Suzhou Industrial Park in 2010, and its core team has decades of experience in the entire life cycle of international drugs, committed to high-quality and differentiated innovative drug research and industrialization. The company has built a rich pipeline of innovative drugs covering hypoglycemic, anticancer, and autoimmune diseases through an integrated drug research and development technology platform and diversified business perspectives.
Products and R&D
Dedicated to the development, manufacture and marketing of small molecule innovative drugs
Industry experience
Laboratory
Patents grantedPatent
News Center
Cooperation
We want to build long-term business relationships with customers from all over the world on a mutually beneficial basis!
Contact Information
Address: Room 101, Bld C11, 218 Xinghu Rd,Suzhou industrial Park,China, 215123
Tel： +86-512-62956960（Recruitment）
+86-512-62956961（marketing）
Copyright © 2022 CGeneTech (Suzhou, China) Co., Ltd.
在线客服添加返回顶部
页面顺滑的滚动
屏蔽页面上图片的alt/title提示
右侧在线客服样式 1,2,3 2
图片alt标题设置： Fland Environmental
表单验证提示文本： The content cannot be empty!
循环体没有内容时： Content is being organized—please wait!
CSS / JS 文件放置地